Low prevalence of contraceptive use among Brazilian women of reproductive age with systemic lupus erythematosus

Brito, Milena Bastos; Casqueiro, Juliana Socorro; Alves, Fernanda Scoppetta Sampaio; Lopes, Jade Braga; Alves, Renata Dantas Monteiro Santana; Santiago, Mittermayer B.

doi:10.1080/01443615.2018.1428289

Cited by 7 publications

(12 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the current study, 35.2% of the patients with SLE received contraceptive consultations in the last year which shows a relatively lower rate compared to other studies ( 8 , 9 , 15 , 16 ). A study in Brazil found that among 85 women with SLE, 53% did not use any contraceptive method but 22% used condoms, 11% used combined oral contraceptives and 7% used hormone injections ( 9 ). In another study in Turkey, 20.3% of SLE patients did not use any contraceptive methods, but using withdrawal and condom were found to be more common (withdrawal 32.7%, condom 28.3%) ( 16 ).…”

Section: Discussioncontrasting

confidence: 73%

“…Additionally, using the copper intrauterine device (IUD) is not believed to be associated with worsening disease activity or infection in women with SLE (5). Despite the crucial importance of contraception in women with SLE, it has been revealed that most of women who are at increased risk for unplanned pregnancy, do not receive appropriate contraceptive counseling (8)(9)(10). Therefore, these women will benefit from careful contraceptive counseling prior to pregnancy which can potentially lead to better maternalfetal outcomes.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Contraceptive Prevalence and Consulting Service in Women with Systemic Lupus Erythematosus: A Cross-Sectional Study

Mobini¹,

Tahamtan²,

Salehi³

et al. 2021

Ethiop J Health Sci

View full text Add to dashboard Cite

BACKGROUND: Systemic lupus erythematosus (SLE), often affects women of childbearing age. Family planning consultation is a major aspect of medical care in these patients because of the risk of disease activation and poor pregnancy and fetal outcomes. The aim of the present study was to evaluate contraceptive prevalence and consulting service in women with SLE.METHODS: In a cross-sectional study, a total of 144 female patients with SLE, ages 15-50, who were presented to rheumatology clinics in Sari, north of Iran, were evaluated. The study was conducted between March 2019 and May 2020. Patients' clinico-demographic profile and fertility information were obtained. Disease activity and damage were assessed by the systemic lupus erythematosus disease activity (SLEDAI) and Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index (SDI).RESULTS: One hundred and forty-four SLE patients of childbearing age participated in this study. From 102 patients with the possibility of pregnancy, 36(35.2%) received contraceptive consultations in last year. Withdrawal was the most prevalent contraceptive method (41.7%), followed by permanent (11.8%), and barrier methods (9%). There were no significant differences in age, disease duration, marriage duration, SDI or SLEDAI scores between the women who received or not received contraceptive counseling (P>0.05).CONCLUSION: Many SLE patients did not receive adequate information about contraception, and it may be associated with many adverse effects on disease activity and pregnancy outcomes. Therefore, contraceptive consultation as an important aspect of patient’s management is strongly suggested.

show abstract

Section: Discussioncontrasting

confidence: 73%

Section: Introductionmentioning

confidence: 99%

Contraceptive Prevalence and Consulting Service in Women with Systemic Lupus Erythematosus: A Cross-Sectional Study

Mobini¹,

Tahamtan²,

Salehi³

et al. 2021

Ethiop J Health Sci

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…A listing of the studies to date examining contraception care among women with SLE is included in Supplementary Table , available on the Arthritis Care & Research website at http://onlinelibrary.wiley.com/doi/10.1002/acr.24346/abstract (8,11–22,28–33). These prior studies have revealed variable rates of contraception use among reproductive‐age women with SLE (22–85%) (11–21), and rates of HEC use among this population are even lower, in the range of 6–9% (19,22). Additionally, studies examining contraceptive counseling in the outpatient setting among women with SLE have shown that 28–59% of patients at risk for pregnancy are not receiving counseling (13,18–20,28), including up to 46% of women using teratogens (29).…”

Section: Discussionmentioning

confidence: 99%

“…Additionally, sterilization is another HEC method for women who desire permanent contraception. Prior studies have revealed variable rates of contraception use among reproductive‐age women with SLE (11–21), and rates of HEC use among this population have been shown to be low, in the range of 6–9%, though slightly higher than the 5% HEC use reported in the general population of reproductive‐age women (19,22).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Racial Differences in Contraception Encounters and Dispensing Among Female Medicaid Beneficiaries With Systemic Lupus Erythematosus

Williams

Costenbader

et al. 2021

Arthritis Care & Research

View full text Add to dashboard Cite

Objective African American and Hispanic women with systemic lupus erythematosus (SLE) have the highest rates of potentially avoidable pregnancy complications, yet racial disparities in family planning among reproductive‐age women with SLE have not been well‐studied. Our objective was to examine whether there are racial differences in contraception encounters and dispensing among US Medicaid‐insured women with SLE. Methods Using Medicaid claims data from 2000–2010, we identified women ages 18–50 years with SLE. We examined contraception encounters and uptake over 24 months. We used multivariable logistic regression to estimate the odds ratio and 95% confidence interval by race/ethnicity of contraception encounters, any contraception dispensing, and highly effective contraception (HEC) use, adjusted for age, region, year, SLE severity, and contraindication to estrogen. We also compared contraception encounters and dispensing among women with SLE to the general population and women with diabetes mellitus. Results We identified 24,693 reproductive‐age women with SLE; 43% were African American, 35% White, 15% Hispanic, 4% Asian, 2% other race, and 1% American Indian/Alaska Native. Nine percent had a contraceptive visit, 10% received any contraception, and 2% received HEC. Compared to White women, African American and Asian women had lower odds of contraception dispensing, and African American women had lower odds of HEC use. Women with SLE were more likely to receive HEC than the general population and women with diabetes mellitus. Conclusion In this study of reproductive‐age women with SLE, African American and Asian women had lower odds of contraception dispensing and African American women had lower odds of HEC use. Further study is needed to understand the factors driving these racial disparities among this population.

show abstract

Patterns of contraceptive use through later reproductive years: a prospective cohort study of Australian women with chronic disease

Egan

Forder

Bateson

et al. 2022

Preprint

View full text Add to dashboard Cite

BackgroundPregnancies among women with chronic disease are associated with poor maternal and fetal outcomes. There is a need to understand how women use or don’t use contraception across their reproductive years to better inform the development of preconception care strategies to reduce high risk unintended pregnancies, including among women of older reproductive age. However, there is a lack of high-quality longitudinal evidence to inform such strategies. We examined patterns of contraceptive use among a population-based cohort of reproductive aged women and investigated how chronic disease influenced contraceptive use over time.Methods and FindingsContraceptive patterns from 8,030 women of reproductive age from the Australian Longitudinal Study on Women’s Health (1973-78 cohort), who were at potential risk of an unintended pregnancy were identified using latent transition analysis. Multinomial mixed-effect logistic regression models were used to evaluate the relationship between contraceptive combinations and chronic disease. Contraception non-use increased between 2006 and 2018 but was similar between women with and without chronic disease (13.6% vs. 12.7% among women aged 40-45 years in 2018). When specific contraceptive use patterns were examined over time, differences were found for women with autoinflammatory diseases only. These women had increased odds of using condom and natural methods (OR=1.20, 95% CI=1.00, 1.44), and sterilisation and other methods (OR=1.61, 95% CI=1.08, 2.39) or no contraception (OR=1.32, 95% CI=1.04, 1.66), compared to women without chronic disease using short-acting methods and condoms.ConclusionPotential gaps in the provision of appropriate contraceptive access and care exist for women with chronic disease, particularly for women diagnosed with autoinflammatory conditions. Development of national guidelines as well as a clear coordinated contraceptive strategy that begins in adolescence and is regularly reviewed during care management through their main reproductive years and into perimenopause is required to increase support for, and agency among, women with chronic disease.

show abstract

Low prevalence of contraceptive use among Brazilian women of reproductive age with systemic lupus erythematosus

Cited by 7 publications

References 17 publications

Contraceptive Prevalence and Consulting Service in Women with Systemic Lupus Erythematosus: A Cross-Sectional Study

Contraceptive Prevalence and Consulting Service in Women with Systemic Lupus Erythematosus: A Cross-Sectional Study

Racial Differences in Contraception Encounters and Dispensing Among Female Medicaid Beneficiaries With Systemic Lupus Erythematosus

Patterns of contraceptive use through later reproductive years: a prospective cohort study of Australian women with chronic disease

Contact Info

Product

Resources

About